Navigation Links
Uroplasty Reports Third Quarter of Fiscal 2012 Financial Results
Date:1/26/2012

ing the call at 800-406-7325 (domestic) or 303-590-3030 (international), with the passcode 4502445#.

About Uroplasty, Inc. Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions.  Our focus is the continued commercialization of our Urgent PC Neuromodulation System, the only FDA-cleared system that delivers posterior tibial nerve stimulation for the office-based treatment of overactive bladder and the associated symptoms of urgency, frequency and urge incontinence.

We also offer Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information on the company and its products, please visit Uroplasty, Inc. at www.uroplasty.com.

Forward-Looking Information This press release contains forward-looking statements that reflect our best estimates regarding future events and financial performance. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from our anticipated results. We discuss in detail the factors that may affect the achievement of our forward-looking statements in our Annual Report on Form 10-K filed with the SEC.  In particular, we cannot be certain that we will ever achieve sustained profitability, that the rate of reimbursement for PTNS treatments will be adequate to justify the cost of our product, that other Medicare carriers or private payers will provide coverage for this treatment or that existing carriers and payers will not change their coverage decisions, that the rate of adoption of our productions by new customers will continue, or that any of the other risks i
'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Uroplasty to Issue Third Quarter 2012 Financial Results on January 26, 2012
2. Uroplasty to Present at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Medical Device Conference
3. Uroplasty Announces Issuance of New Apparatus Patent for the Urgent® PC Neuromodulation System Stimulator
4. Uroplasty Reports Fiscal Second Quarter 2012 Financial Results
5. Uroplasty to Issue Second Quarter 2012 Financial Results on October 27, 2011
6. Uroplasty to Present at the 6th Annual JMP Securities Healthcare Conference
7. Uroplasty Reports Financial Results for the First Quarter of Fiscal 2012
8. Uroplasty to Issue First Quarter 2012 Financial Results on July 28, 2011
9. Two Additional Private Payers Provide Coverage for Posterior Tibial Nerve Stimulation Delivered Using the Uroplasty Urgent® PC Neuromodulation System
10. Uroplasty on Preliminary List of Additions to Russell 3000® and Russell Global® Indexes
11. Uroplastys Dave Kaysen to Ring NASDAQ Closing Bell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... , 25. April 2015 Hospira, ... in der Entwicklung von Biosimilar-Behandlungen, sprach heute auf ... Europäischen Generikaverbands (EGA) in London ... mit der Verfügbarkeit von Biosimilars für Patienten. ... maßgeblichen White Papers mit dem Titel „Why ...
(Date:4/24/2015)... April 24, 2015   Bernstein Liebhard LLP ... ("Aerie" or the "Company") (NASDAQ: AERI ) ... in violation of the federal securities laws; or ... their fiduciary duties to shareholders. Aerie ... discovery, development and commercialization of first-in-class therapies for ...
(Date:4/24/2015)... PORTLAND, Ore. , April 24, 2015  A new ... in the costs of drugs used to slow the progression ... to a study led by researchers at Oregon Health & ... A substantial increase in the number of MS drugs in ... lead to lower or stabilized costs for patients who use ...
Breaking Medicine Technology:Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 2Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 3Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 4Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 5Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 6Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 7Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 8Bernstein Liebhard LLP Investigates Claims On Behalf Of Those Who Invested In Aerie Pharmaceuticals, Inc. 2Researchers find alarming rise in cost of MS drugs over past two decades 2Researchers find alarming rise in cost of MS drugs over past two decades 3Researchers find alarming rise in cost of MS drugs over past two decades 4
... 2011 NeuroSigma, Inc., a Los Angeles-based medical ... notice of award for an NIH Small Business ... National Institute of Neurological Disorders and Stroke (NINDS). ... nerve stimulation (eTNS™) therapy for the treatment of ...
... 2011 Reportlinker.com announces that ... is available in its catalogue: ... Market in India - Strategic ... Pharmaceutical Players are the Driving ...
Cached Medicine Technology:NeuroSigma Receives Notice of Award from NIH for an STTR Grant for its Trigeminal Nerve Stimulation Therapy for Epilepsy 2Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 2Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 3Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 4Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 5Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 6Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 7Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 8Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 9Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 10Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 11
(Date:4/27/2015)... April 27, 2015 Douglas Fitzpatrick ... his clients feel secure, but also helps secure homes for ... p.m., Douglas will be manning a booth at the 2015 ... Building, 717 E. 17th Ave., Columbus, Ohio. , “I ... that will feature hundreds of adoptable pets from more than ...
(Date:4/27/2015)... April 27, 2015 On May 15, ... a social media campaign to raise awareness of the ... Mamas; and Sri Somesvara Temple. Ironically, when many of ... North Carolina, they thought they were leaving the social ... least six months of meditation, service to a higher ...
(Date:4/27/2015)... Attorney Dan Newlin, of the Law Offices of Dan ... that commitment to a whole new level with the introduction ... for existing and potential clients to contact the law firm. ... value to the firm’s services, #Dan covers Central Florida, South ... offices. , “I knew the pound sign (#) could be ...
(Date:4/27/2015)... Miami, FL (PRWEB) April 27, 2015 ... policies from arresting nonviolent drug offenders to providing drug ... by Nepr on April 8th. Several states, ... cut state costs revolving incarceration. Texas has formed community ... populace. According to The Council of State Governments ...
(Date:4/27/2015)... Climate change predictions are largely based on ... of variables used and the availability of large amounts ... Gerald Pollack, PhD, and Climatologist L.DeWayne Cecil, PhD, appearing ... show, noted three potential weaknesses that could impact the ... individuals dispute that Earth’s climate is changing. Nor do ...
Breaking Medicine News(10 mins):Health News:Farmers Insurance Agent Douglas Fitzpatrick Ensures Pets Find Homes 2Health News:Mount Soma Monks Do Social Media 2Health News:Dan Newlin Hashtags It With #Dan 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 3Health News:Global warming: Computer weather models flawed report Climatologist, Water Researcher on Sharon Kleyne Hour™ radio show 2Health News:Global warming: Computer weather models flawed report Climatologist, Water Researcher on Sharon Kleyne Hour™ radio show 3
... breast cancer on screening mammography report no family history, a new ... Care, LLC in Rochester, NY of all breast cancers diagnosed between ... were found in women, aged 40-49 with no family history of ... a prior personal history of breast cancer or abnormal cells at ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, ... a heart valve disease known as aortic stenosis, a ... effective, French researchers say. Transcatheter aortic-valve implantation is ... valve than traditional open-heart surgery. The procedure involves passing ...
... HealthDay Reporter , WEDNESDAY, May 2 (HealthDay News) -- ... (bird) flu virus can morph -- with the possibility that it ... -- may help nations prepare for the impending threat. That,s ... study in the May 2 online issue of Nature , ...
... mTOR stops the growth of primary liver cancer and destroys ... Group of Metabolism and Cancer at Bellvitge Biomedical Research Institute ... edition of the journal Science Translational Medicine . ... common cancer and, due to its aggressiveness, is the third ...
... 2012. Kessler Foundation will be represented by four scientists at ... to be held at the Congress Center in Bordeaux, France ... Foundation,s VP of Research and Training will attend with research ... PhD. Kessler Foundation is known for rehabilitation research ...
... 2 (HealthDay News) -- Chemistry in three areas of ... small study says. Along with providing new information ... important in finding ways to treat depression, schizophrenia, attention-deficit ... decreased motivation, Vanderbilt University researchers said. The researchers ...
Cached Medicine News:Health News:Less Invasive Heart Valve Replacement Works for Elderly: Study 2Health News:Less Invasive Heart Valve Replacement Works for Elderly: Study 3Health News:Once-Banned Bird Flu Study Suggests Pandemic Threat Is Real 2Health News:Once-Banned Bird Flu Study Suggests Pandemic Threat Is Real 3Health News:Combination of 2 drugs reverses liver tumors 2Health News:Clues to 'Slacker' Behavior Found in Brain, Study Says 2
... Dolphin Medicals ONE™ technology is ... that uses a patented digital ... use an analog sensor. Dolphin ... digitize the signal in the ...
... Scientific Resolve Immersion Oil is a ... transmission throughout most of the UV-VIS ... low and high viscosity, is non-drying ... index of 1.5150. Resolve contains no ...
Immersion oil composed on polyester polyol, diphenyl cresyl phosphate and tricyclodecane dimethanol....
Immersion oils may crystallize on storage. Can be redissolved on heating to 50ºC (1-2 hours)...
Medicine Products: